What Researchers Did
Researchers in a clinic looked back at patient files from 2004 to 2010 and compared four treatments for sudden hearing loss of unknown cause: oral steroid, steroid placed in the middle ear, hyperbaric oxygen, and oral steroid plus hyperbaric oxygen.
What They Found
In this retrospective study of 217 patients (219 ears) with idiopathic sudden sensorineural hearing loss, the group that received oral steroid plus hyperbaric oxygen had the highest response rate, at 86.88% (53 of 61). The oral steroid group responded at 63.79% (37 of 58), the intratympanic steroid group at 46.51% (20 of 43), and the hyperbaric oxygen group at 43.85% (25 of 57). Complete recovery was also highest in the oral steroid plus hyperbaric oxygen group at 42.6% (26 of 61), compared with 19.0% for oral steroid, 17.5% for hyperbaric oxygen and 11.6% for intratympanic steroid. The combined group also had the highest mean hearing gain, with p less than 0.05 reported.
What This Means for Canadian Patients
For people with sudden hearing loss of unknown cause, this study found that patients who received oral steroid plus hyperbaric oxygen had a higher likelihood of recovery than patients who received any single treatment. Because the patients were not assigned to treatments at random, the results show an association in past records and do not prove that the combination caused the better outcomes. Anyone considering treatment should talk with their own hearing specialist.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study looked back at existing patient files and did not assign patients to groups at random, so differences between the groups may reflect factors other than the treatment received, and the abstract does not give details of the oxygen treatment protocol.